Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
RADIENT PHARMACEUTICALS CorpListing unverified | Buy | $23.5K | conv 62Cluster | SEC | |
RADIENT PHARMACEUTICALS CorpListing unverified | Buy | $2.4K | conv 51ClusterFirst in 12mo | SEC | |
RADIENT PHARMACEUTICALS CorpListing unverified | Buy | $270 | conv 47ClusterFirst in 12mo | SEC | |
RADIENT PHARMACEUTICALS CorpListing unverified | AwardD (derivative) | $1M | SEC | ||
RADIENT PHARMACEUTICALS CorpListing unverified | Exercise | $168K | SEC | ||
RADIENT PHARMACEUTICALS CorpListing unverified | ExerciseD (derivative) | $168K | SEC | ||
RADIENT PHARMACEUTICALS CorpListing unverified | Sell | $187.6K | SEC | ||
RADIENT PHARMACEUTICALS CorpListing unverified | AwardD (derivative) | $698.3K | SEC | ||
RADIENT PHARMACEUTICALS CorpListing unverified | AwardD (derivative) | $740K | SEC | ||
RADIENT PHARMACEUTICALS CorpListing unverified | AwardD (derivative) | $171K | SEC | ||
RADIENT PHARMACEUTICALS CorpListing unverified | AwardD (derivative) | $249K | SEC | ||
RADIENT PHARMACEUTICALS CorpListing unverified | AwardD (derivative) | $232.5K | SEC | ||
RADIENT PHARMACEUTICALS CorpListing unverified | AwardD (derivative) | $861K | SEC | ||
Archer-Daniels-Midland CoListing on record | AwardD (derivative) | $269.5K | SEC |